MSF

Sound the alarm: We are failing to meet targets to beat TB but Khayelitsha’s care model during COVID-19 shows exactly how it should be done

During the course of the 52nd Union World Conference on Lung Health last week, Doctors Without Borders (MSF) announced the results of TB-PRACTECAL, the first-ever multi-country, randomised, controlled clinical trial to report on the effectiveness and safety of a six-month…

Read More » Sound the alarm: We are failing to meet targets to beat TB but Khayelitsha’s care model during COVID-19 shows exactly how it should be done

A breakthrough in the treatment of drug-resistant TB signals shorter and safer treatment for patients

People battling rifampicin-resistant tuberculosis (RR-TB) could soon have access to a shorter and safer course of treatment. Doctors without Borders (MSF) have released the results from a clinical trial on an all oral six-month treatment regime. Current treatment can last…

Read More » A breakthrough in the treatment of drug-resistant TB signals shorter and safer treatment for patients

In Focus: Global strategy to end cryptococcal meningitis in people living with HIV

Cryptococcal meningitis is the second biggest killer of people living with HIV after tuberculosis (TB). Now, a global initiative, the Ending Cryptococcal Meningitis Deaths by 2030 Strategic Framework aims to get the gold standard drug to treat the disease – flucytosine – registered in countries that need it. By Amy Green for Spotlight and Health-e News.
Read More » In Focus: Global strategy to end cryptococcal meningitis in people living with HIV

Newsletter Subscription